Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 757 to 768 of 771 entries
Sorted by: Best Match Show Resources per page
Association between recorded medication reviews in primary care and adequate drug treatment management - a cross-sectional study.

Scandinavian journal of primary health care

Parodi López N, Svensson SA, Wallerstedt SM.
PMID: 34549673
Scand J Prim Health Care. 2021 Dec;39(4):419-428. doi: 10.1080/02813432.2021.1973239. Epub 2021 Sep 22.

OBJECTIVE: To investigate the association between a recorded procedure code for a medication review and adequate drug treatment management, and to explore factors associated with this code.DESIGN AND SETTING: Cross-sectional study; two primary health care centres, in Region Västra...

Cite
Parodi López N, Svensson SA, Wallerstedt SM. Association between recorded medication reviews in primary care and adequate drug treatment management - a cross-sectional study. Scand J Prim Health Care. 2021;39(4):419-428doi: 10.1080/02813432.2021.1973239.
Parodi López, N., Svensson, S. A., & Wallerstedt, S. M. (2021). Association between recorded medication reviews in primary care and adequate drug treatment management - a cross-sectional study. Scandinavian journal of primary health care, 39(4), 419-428. https://doi.org/10.1080/02813432.2021.1973239
Parodi López, Naldy, et al. "Association between recorded medication reviews in primary care and adequate drug treatment management - a cross-sectional study." Scandinavian journal of primary health care vol. 39,4 (2021): 419-428. doi: https://doi.org/10.1080/02813432.2021.1973239
Parodi López N, Svensson SA, Wallerstedt SM. Association between recorded medication reviews in primary care and adequate drug treatment management - a cross-sectional study. Scand J Prim Health Care. 2021 Dec;39(4):419-428. doi: 10.1080/02813432.2021.1973239. Epub 2021 Sep 22. PMID: 34549673.
Copy Download .nbib Format: NLM
Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs.

JAMA network open

Rome BN, Feldman WB, Desai RJ, Kesselheim AS.
PMID: 33944925
JAMA Netw Open. 2021 May 03;4(5):e218816. doi: 10.1001/jamanetworkopen.2021.8816.

IMPORTANCE: List prices set by manufacturers for brand-name prescription drugs in the US have been increasing faster than inflation, although confidential manufacturer rebates offset some of these increases. Most commercially insured patients pay at least some out-of-pocket costs for...

Cite
Rome BN, Feldman WB, Desai RJ, et al. Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs. JAMA Netw Open. 2021;4(5):e218816doi: 10.1001/jamanetworkopen.2021.8816.
Rome, B. N., Feldman, W. B., Desai, R. J., & Kesselheim, A. S. (2021). Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs. JAMA network open, 4(5), e218816. https://doi.org/10.1001/jamanetworkopen.2021.8816
Rome, Benjamin N, et al. "Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs." JAMA network open vol. 4,5 (2021): e218816. doi: https://doi.org/10.1001/jamanetworkopen.2021.8816
Rome BN, Feldman WB, Desai RJ, Kesselheim AS. Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs. JAMA Netw Open. 2021 May 03;4(5):e218816. doi: 10.1001/jamanetworkopen.2021.8816. PMID: 33944925; PMCID: PMC8097497.
Copy Download .nbib Format: NLM
New Drugs 2021, Part 2.

Nursing

[No authors listed]
PMID: 34580259
Nursing. 2021 Oct 01;51(10):29-30. doi: 10.1097/01.NURSE.0000795252.50733.48.

No abstract available.

Cite
New Drugs 2021, Part 2. Nursing. 2021;51(10):29-30doi: 10.1097/01.NURSE.0000795252.50733.48.
(2021). New Drugs 2021, Part 2. Nursing, 51(10), 29-30. https://doi.org/10.1097/01.NURSE.0000795252.50733.48
"New Drugs 2021, Part 2." Nursing vol. 51,10 (2021): 29-30. doi: https://doi.org/10.1097/01.NURSE.0000795252.50733.48
New Drugs 2021, Part 2. Nursing. 2021 Oct 01;51(10):29-30. doi: 10.1097/01.NURSE.0000795252.50733.48. PMID: 34580259.
Copy Download .nbib Format: NLM
Increased Patient's Risk Associated with the Canadian Bioequivalence Guidance Due to Outlier Removal.

Therapeutic innovation & regulatory science

Fuglsang A.
PMID: 34719007
Ther Innov Regul Sci. 2021 Oct 30; doi: 10.1007/s43441-021-00344-2. Epub 2021 Oct 30.

BACKGROUND: The Canadian guideline on bioequivalence allows identification of outliers through for example studentized residuals, and it explicitly accepts exclusion of subject data when their studentized residuals reach a certain magnitude. The guideline also requires that the type I...

Cite
Fuglsang A. Increased Patient's Risk Associated with the Canadian Bioequivalence Guidance Due to Outlier Removal. Ther Innov Regul Sci. 2021;doi: 10.1007/s43441-021-00344-2.
Fuglsang, A. (2021). Increased Patient's Risk Associated with the Canadian Bioequivalence Guidance Due to Outlier Removal. Therapeutic innovation & regulatory science, . https://doi.org/10.1007/s43441-021-00344-2
Fuglsang, Anders. "Increased Patient's Risk Associated with the Canadian Bioequivalence Guidance Due to Outlier Removal." Therapeutic innovation & regulatory science vol. (2021). doi: https://doi.org/10.1007/s43441-021-00344-2
Fuglsang A. Increased Patient's Risk Associated with the Canadian Bioequivalence Guidance Due to Outlier Removal. Ther Innov Regul Sci. 2021 Oct 30; doi: 10.1007/s43441-021-00344-2. Epub 2021 Oct 30. PMID: 34719007.
Copy Download .nbib Format: NLM
Insulin insulated: barriers to competition and affordability in the United States insulin market.

Journal of law and the biosciences

Knox R.
PMID: 34221426
J Law Biosci. 2020 Oct 09;7(1):lsaa061. doi: 10.1093/jlb/lsaa061. eCollection 2020.

Insulin prices in the United States are skyrocketing. In addition to several challenges common to high-priced prescription drugs, insulin faces several unique legal, regulatory, and practical challenges to increasing access and affordability. Despite the fact that insulin was developed...

Cite
Knox R. Insulin insulated: barriers to competition and affordability in the United States insulin market. J Law Biosci. 2020;7(1):lsaa061doi: 10.1093/jlb/lsaa061.
Knox, R. (2020). Insulin insulated: barriers to competition and affordability in the United States insulin market. Journal of law and the biosciences, 7(1), lsaa061. https://doi.org/10.1093/jlb/lsaa061
Knox, Ryan. "Insulin insulated: barriers to competition and affordability in the United States insulin market." Journal of law and the biosciences vol. 7,1 (2020): lsaa061. doi: https://doi.org/10.1093/jlb/lsaa061
Knox R. Insulin insulated: barriers to competition and affordability in the United States insulin market. J Law Biosci. 2020 Oct 09;7(1):lsaa061. doi: 10.1093/jlb/lsaa061. eCollection 2020. PMID: 34221426; PMCID: PMC8249113.
Copy Download .nbib Format: NLM
Direct-to-Consumer Sale of Prescription Drugs by Pharmaceutical Companies: An Assessment of the Patient Experience?.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians

Seal D, Jackson S, Brooks J, Harris K, Haskell A, Ransom R.
PMID: 34860979
J Pharm Technol. 2016 Jun;32(3):98-103. doi: 10.1177/8755122515627361. Epub 2016 Feb 17.

No abstract available.

Cite
Seal D, Jackson S, Brooks J, et al. Direct-to-Consumer Sale of Prescription Drugs by Pharmaceutical Companies: An Assessment of the Patient Experience?. J Pharm Technol. 2016;32(3):98-103doi: 10.1177/8755122515627361.
Seal, D., Jackson, S., Brooks, J., Harris, K., Haskell, A., & Ransom, R. (2016). Direct-to-Consumer Sale of Prescription Drugs by Pharmaceutical Companies: An Assessment of the Patient Experience?. The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians, 32(3), 98-103. https://doi.org/10.1177/8755122515627361
Seal, David, et al. "Direct-to-Consumer Sale of Prescription Drugs by Pharmaceutical Companies: An Assessment of the Patient Experience?." The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians vol. 32,3 (2016): 98-103. doi: https://doi.org/10.1177/8755122515627361
Seal D, Jackson S, Brooks J, Harris K, Haskell A, Ransom R. Direct-to-Consumer Sale of Prescription Drugs by Pharmaceutical Companies: An Assessment of the Patient Experience?. J Pharm Technol. 2016 Jun;32(3):98-103. doi: 10.1177/8755122515627361. Epub 2016 Feb 17. PMID: 34860979; PMCID: PMC5998458.
Copy Download .nbib Format: NLM
Pursuing Value-Based Prices for Drugs: A Comprehensive Comparison of State Prescription Drug-Pricing Boards.

The Milbank quarterly

Bendicksen L, Rome BN, Avorn J, Kesselheim AS.
PMID: 34375015
Milbank Q. 2021 Dec;99(4):1162-1197. doi: 10.1111/1468-0009.12533. Epub 2021 Aug 10.

Policy Points In the absence of federal action on rising prescription drug costs, we reviewed the details of five states that have enacted prescription drug-pricing boards seeking to lower drug prices based on products' value. Within these states, six...

Cite
Bendicksen L, Rome BN, Avorn J, et al. Pursuing Value-Based Prices for Drugs: A Comprehensive Comparison of State Prescription Drug-Pricing Boards. Milbank Q. 2021;99(4):1162-1197doi: 10.1111/1468-0009.12533.
Bendicksen, L., Rome, B. N., Avorn, J., & Kesselheim, A. S. (2021). Pursuing Value-Based Prices for Drugs: A Comprehensive Comparison of State Prescription Drug-Pricing Boards. The Milbank quarterly, 99(4), 1162-1197. https://doi.org/10.1111/1468-0009.12533
Bendicksen, Liam, et al. "Pursuing Value-Based Prices for Drugs: A Comprehensive Comparison of State Prescription Drug-Pricing Boards." The Milbank quarterly vol. 99,4 (2021): 1162-1197. doi: https://doi.org/10.1111/1468-0009.12533
Bendicksen L, Rome BN, Avorn J, Kesselheim AS. Pursuing Value-Based Prices for Drugs: A Comprehensive Comparison of State Prescription Drug-Pricing Boards. Milbank Q. 2021 Dec;99(4):1162-1197. doi: 10.1111/1468-0009.12533. Epub 2021 Aug 10. PMID: 34375015; PMCID: PMC8718587.
Copy Download .nbib Format: NLM
Prescription Drug and Cannabis Use among Recent Latinx Immigrants Pre- and Post-Immigration to the US.

Substance use & misuse

Westrick AC, Vazquez V, De La Rosa M, Romano E, Rojas P, Sanchez M.
PMID: 34898352
Subst Use Misuse. 2021 Dec 13;1-10. doi: 10.1080/10826084.2021.1990342. Epub 2021 Dec 13.

No abstract available.

Cite
Westrick AC, Vazquez V, De La Rosa M, et al. Prescription Drug and Cannabis Use among Recent Latinx Immigrants Pre- and Post-Immigration to the US. Subst Use Misuse. 2021;1-10doi: 10.1080/10826084.2021.1990342.
Westrick, A. C., Vazquez, V., De La Rosa, M., Romano, E., Rojas, P., & Sanchez, M. (2021). Prescription Drug and Cannabis Use among Recent Latinx Immigrants Pre- and Post-Immigration to the US. Substance use & misuse, 1-10. https://doi.org/10.1080/10826084.2021.1990342
Westrick, Ashly C, et al. "Prescription Drug and Cannabis Use among Recent Latinx Immigrants Pre- and Post-Immigration to the US." Substance use & misuse vol. (2021): 1-10. doi: https://doi.org/10.1080/10826084.2021.1990342
Westrick AC, Vazquez V, De La Rosa M, Romano E, Rojas P, Sanchez M. Prescription Drug and Cannabis Use among Recent Latinx Immigrants Pre- and Post-Immigration to the US. Subst Use Misuse. 2021 Dec 13;1-10. doi: 10.1080/10826084.2021.1990342. Epub 2021 Dec 13. PMID: 34898352.
Copy Download .nbib Format: NLM
Assessment of use of psychoactive and other non-prescription drugs among students of selected tertiary institutions in Ekiti State South West Nigeria - A baseline study.

Heliyon

Soremekun RO, Omole OE, Adeyemi OC, Oshatimi AM.
PMID: 33681493
Heliyon. 2021 Feb 26;7(2):e06232. doi: 10.1016/j.heliyon.2021.e06232. eCollection 2021 Feb.

BACKGROUND: Substance abuse is causing increasing threats to the stability of young minds, from teenage to the older youths and is an issue of public health concern in Nigeria. This study was carried out to determine the prevalence of...

Cite
Soremekun RO, Omole OE, Adeyemi OC, et al. Assessment of use of psychoactive and other non-prescription drugs among students of selected tertiary institutions in Ekiti State South West Nigeria - A baseline study. Heliyon. 2021;7(2):e06232doi: 10.1016/j.heliyon.2021.e06232.
Soremekun, R. O., Omole, O. E., Adeyemi, O. C., & Oshatimi, A. M. (2021). Assessment of use of psychoactive and other non-prescription drugs among students of selected tertiary institutions in Ekiti State South West Nigeria - A baseline study. Heliyon, 7(2), e06232. https://doi.org/10.1016/j.heliyon.2021.e06232
Soremekun, Rebecca O, et al. "Assessment of use of psychoactive and other non-prescription drugs among students of selected tertiary institutions in Ekiti State South West Nigeria - A baseline study." Heliyon vol. 7,2 (2021): e06232. doi: https://doi.org/10.1016/j.heliyon.2021.e06232
Soremekun RO, Omole OE, Adeyemi OC, Oshatimi AM. Assessment of use of psychoactive and other non-prescription drugs among students of selected tertiary institutions in Ekiti State South West Nigeria - A baseline study. Heliyon. 2021 Feb 26;7(2):e06232. doi: 10.1016/j.heliyon.2021.e06232. eCollection 2021 Feb. PMID: 33681493; PMCID: PMC7930107.
Copy Download .nbib Format: NLM
Purchasing prescription drugs in Canada: hang together or hang separately.

Healthcare policy = Politiques de sante

Law MR, Morgan SG.
PMID: 22548094
Healthc Policy. 2011 May;6(4):22-6.

Canada's provincial and territorial governments have expressed an interest in bulk purchasing prescription drugs for many years. We propose they start by purchasing selected generic drugs for the entire population and provide them for little or no cost to...

Cite
Law MR, Morgan SG. Purchasing prescription drugs in Canada: hang together or hang separately. Healthc Policy. 2011;6(4):22-6
Law, M. R., & Morgan, S. G. (2011). Purchasing prescription drugs in Canada: hang together or hang separately. Healthcare policy = Politiques de sante, 6(4), 22-6.
Law, Michael R, and Morgan, Steven G. "Purchasing prescription drugs in Canada: hang together or hang separately." Healthcare policy = Politiques de sante vol. 6,4 (2011): 22-6.
Law MR, Morgan SG. Purchasing prescription drugs in Canada: hang together or hang separately. Healthc Policy. 2011 May;6(4):22-6. PMID: 22548094; PMCID: PMC3107113.
Copy Download .nbib Format: NLM
Cartilage targeted chemical delivery of naproxen and ibuprofen for the treatment of arthritis.

Journal of pharmacy & bioallied sciences

Pawar V, Gohil V, Tamboli R, Giridhar R, Yadav MR.
PMID: 23066177
J Pharm Bioallied Sci. 2012 Mar;4:S10-1. doi: 10.4103/0975-7406.94119.

NSAIDs are among the most widely used prescription drugs, for the treatment of pain and inflammation, particularly arthritis. Inhibitor of COX and NSAIDs relieve the signs and symptoms of inflammation by decreasing PG production but may cause GI and...

Cite
Pawar V, Gohil V, Tamboli R, et al. Cartilage targeted chemical delivery of naproxen and ibuprofen for the treatment of arthritis. J Pharm Bioallied Sci. 2012;4:S10-1doi: 10.4103/0975-7406.94119.
Pawar, V., Gohil, V., Tamboli, R., Giridhar, R., & Yadav, M. R. (2012). Cartilage targeted chemical delivery of naproxen and ibuprofen for the treatment of arthritis. Journal of pharmacy & bioallied sciences, 4S10-1. https://doi.org/10.4103/0975-7406.94119
Pawar, Vijay, et al. "Cartilage targeted chemical delivery of naproxen and ibuprofen for the treatment of arthritis." Journal of pharmacy & bioallied sciences vol. 4 (2012): S10-1. doi: https://doi.org/10.4103/0975-7406.94119
Pawar V, Gohil V, Tamboli R, Giridhar R, Yadav MR. Cartilage targeted chemical delivery of naproxen and ibuprofen for the treatment of arthritis. J Pharm Bioallied Sci. 2012 Mar;4:S10-1. doi: 10.4103/0975-7406.94119. PMID: 23066177; PMCID: PMC3467844.
Copy Download .nbib Format: NLM
Incremental Healthcare Resource Utilization and Expenditures Associated with Cardiovascular Diseases in Patients with Diabetes: A Cross-Sectional Study.

Iranian journal of medical sciences

Ebrahimoghli R, Janati A, Sadeghi-Bazargani H, Hamishehkar H, Khalili-Azimi A.
PMID: 35017778
Iran J Med Sci. 2022 Jan;47(1):53-62. doi: 10.30476/ijms.2020.87284.1742.

BACKGROUND: Cardiovascular disease (CVD) is the most prevalent comorbid condition among patients with diabetes. The objective of this study is to determine the incremental healthcare resource utilization and expenditures (HRUE) associated with CVD comorbidity in diabetic patients.METHODS: In a...

Cite
Ebrahimoghli R, Janati A, Sadeghi-Bazargani H, et al. Incremental Healthcare Resource Utilization and Expenditures Associated with Cardiovascular Diseases in Patients with Diabetes: A Cross-Sectional Study. Iran J Med Sci. 2022;47(1):53-62doi: 10.30476/ijms.2020.87284.1742.
Ebrahimoghli, R., Janati, A., Sadeghi-Bazargani, H., Hamishehkar, H., & Khalili-Azimi, A. (2022). Incremental Healthcare Resource Utilization and Expenditures Associated with Cardiovascular Diseases in Patients with Diabetes: A Cross-Sectional Study. Iranian journal of medical sciences, 47(1), 53-62. https://doi.org/10.30476/ijms.2020.87284.1742
Ebrahimoghli, Reza, et al. "Incremental Healthcare Resource Utilization and Expenditures Associated with Cardiovascular Diseases in Patients with Diabetes: A Cross-Sectional Study." Iranian journal of medical sciences vol. 47,1 (2022): 53-62. doi: https://doi.org/10.30476/ijms.2020.87284.1742
Ebrahimoghli R, Janati A, Sadeghi-Bazargani H, Hamishehkar H, Khalili-Azimi A. Incremental Healthcare Resource Utilization and Expenditures Associated with Cardiovascular Diseases in Patients with Diabetes: A Cross-Sectional Study. Iran J Med Sci. 2022 Jan;47(1):53-62. doi: 10.30476/ijms.2020.87284.1742. PMID: 35017778; PMCID: PMC8743375.
Copy Download .nbib Format: NLM
Showing 757 to 768 of 771 entries